Summary
A case of diabetic lipodystrophy which showed an improvement after continuous subcutan eous insulin infusion into lipodystrophic areas is reported. The authors feel that this therapeutic regimen could be useful when conventional treatments (the injection of regular purified insulin or dexamethasone-insulin mixtures in the area of the lesion) have failed to obtain good results.
Similar content being viewed by others
References
Kuman D., Miller L. V., Methalia S. D.: Use of dexamethasone in treatment of insulin lipoatrophy—Diabetes26, 296, 1977.
Renold A. E., Winegrad A. I., Martin D. B.: Diabete sucré et tissu adipeux—Helv. med. Acta24, 322, 1957.
Wentworth S. M., Galloway J. A., Hawiz E. A.: The use of purified insulins in treatment of patients with insulin lipoatrophy—Diabetes22 (Suppl. 1), 290 A, 1973; Abstract # 8.
Withley T. H., Lawerence P. A., Smith C. L.: Amelioration of insulin atrophy by dexamethasome injections—J. Amer. med Ass.235 839 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cimino, A., Valentini, U., Rotondi, A. et al. Continuous subcutaneous insulin infusion (CSII) in the management of diabetic lipodystrophy: a case report. Acta diabet. lat 24, 165–167 (1987). https://doi.org/10.1007/BF02742855
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02742855